ADA 2026: Semaglutide Plus Dapagliflozin Improved HbA1c in Overweight Adults With T1DM Tags Hypoglycemia hBA1c GLP-1 agonists SGLT-2 Inhibitor Read more about ADA 2026: Semaglutide Plus Dapagliflozin Improved HbA1c in Overweight Adults With T1DM
Oral Elecoglipron Reduced HbA1c by Up to 1.9% in T2DM Tags GLP-1 agonists hBA1c Read more about Oral Elecoglipron Reduced HbA1c by Up to 1.9% in T2DM
GLP-1 RAs Outperformed DPP-4 Inhibitors on CV Outcomes in Dialysis-Treated T2DM Tags DPP-4 inhibitors GLP-1 agonists Read more about GLP-1 RAs Outperformed DPP-4 Inhibitors on CV Outcomes in Dialysis-Treated T2DM
ADA 2026: Icovamenib Improved HbA1c in T2DM on GLP-1 RAs Tags GLP-1 agonists hBA1c Read more about ADA 2026: Icovamenib Improved HbA1c in T2DM on GLP-1 RAs
ADA 2026: Semaglutide Showed Higher Reporting Odds for Select AEs Tags GLP-1 agonists Biguanide Read more about ADA 2026: Semaglutide Showed Higher Reporting Odds for Select AEs
ADA 2026: Oral Semaglutide 25 mg Achieved Nearly 8-kg Weight Reduction Tags GLP-1 agonists hBA1c Read more about ADA 2026: Oral Semaglutide 25 mg Achieved Nearly 8-kg Weight Reduction
ADA 2026: GL0034 Improved Weight and Glycemic Control in T2DM Tags GLP-1 agonists hBA1c Read more about ADA 2026: GL0034 Improved Weight and Glycemic Control in T2DM
Retatrutide Delivered Dual HbA1c and Weight Benefits in T2DM Tags GLP-1 agonists hBA1c Read more about Retatrutide Delivered Dual HbA1c and Weight Benefits in T2DM
Cagrilintide-Semaglutide Improved HbA1c More Than Semaglutide in T2DM Tags hBA1c GLP-1 agonists SGLT-2 Inhibitor Read more about Cagrilintide-Semaglutide Improved HbA1c More Than Semaglutide in T2DM
ADA 2026: PG-102 Lowered HbA1c With Biweekly and Monthly Dosing Tags FBS GLP-1 agonists hBA1c Read more about ADA 2026: PG-102 Lowered HbA1c With Biweekly and Monthly Dosing